Figure 2From: KRAS, BRAF genotyping reveals genetic heterogeneity of ovarian borderline tumors and associated implants Representative pyro-sequencing mutation analysis results are shown. The BRAF wildtype allele (A) is frequently mutated (B; p.V600E) in s-BOTs and implants. An amino acid substitution at codon 12 in KRAS (D; p.G12A) alters wildtype KRAS (C).Back to article page